MedPath

Investigation of the reasons for withdrawal from long-term treatment with mirabegron of treatment-naive Japanese female patients with overactive bladder in the real-world clinical setting

Not Applicable
Conditions
Overactive bladder
Registration Number
JPRN-UMIN000029048
Lead Sponsor
Hokkaido Prefectural Esashi Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
70
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with premenopausal, urinary tract infection, large postvoid residual volume (more than 150 mL), a previous treatment history for OAB, and contraindications to use of mirabegron

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath